Sung Ji Nam is a Senior Research Analyst at Avondale Partners, LLC in the health care sector focusing on life science tools and diagnostics. Prior to joining Avondale Partners, LLC, she served as Senior Analyst covering life science tools and diagnostics at Cantor Fitzgerald and Gleacher and Company, where she was recognized as 2011 Institutional Investor Rising Star in life science and diagnostic tools. Ms. Nam began her career in equity research at J.P. Morgan as a Vice President/Associate Analyst on a team covering life science tools, diagnostics, small-to-midcap medical technology and contract research organizations. Mr. Nam also has prior experience as a Senior Program Officer of science, higher education and health care at the Gordon and Betty Moore Foundation, and in health care investment banking at Robertson Stephens. Mr. Nam holds a B.A. in chemistry and an MBA from Harvard University.